Stuhlmiller, Timothy J <br/><br/>
Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains.  [electronic resource] 

 -  Cell reports  Apr 2015 
 - 390-404 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2211-1247 
<br/><br/><label>Standard No.: </label>10.1016/j.celrep.2015.03.037  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Blotting, Western<br/>Breast Neoplasms--metabolism<br/>Cell Line, Tumor<br/>Drug Resistance, Neoplasm--physiology<br/>Female<br/>Humans<br/>Lapatinib<br/>Mass Spectrometry<br/>Oligonucleotide Array Sequence Analysis<br/>Polymerase Chain Reaction<br/>Protein Kinase Inhibitors--pharmacology<br/>Proteomics<br/>Quinazolines--pharmacology<br/>Receptor, ErbB-2--metabolism<br/>Signal Transduction--physiology<br/>Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization